HIGHLIGHTS
- who: Gianfranco Vitiello from the National and Kapodistrian University of Athens, Greece have published the research: Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis, in the Journal: (JOURNAL)
- what: This study supports previous CALIMA/SIROCCO responder analyses, where CRSwNP was identified as a clinical characteristic of enhanced response to benralizumab.
- how: Statistical analysis was described in the full manuscript . In the study BEC was found to be higher in patients with SEA and CRSwNP when compared to patients without (median . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.